Year-End Report 2011

Year-End Report 2011

 

Highlights during the fourth quarter

  · Net asset value amounted to SEK 156.1 bn., or SEK 205 per share on December
31, 2011, an increase by SEK 12.0 bn., or SEK 16 per share during the quarter.
  · Investments of SEK 2.1 bn. were made in ABB, Ericsson and Electrolux.
  · Mölnlycke Health Care surpassed the EUR 1 bn. annual sales mark.
  · Investor Growth Capital distributed SEK 229 m. to Investor.
  · The cost savings reducing annual management cost by SEK 140 m. with full
run-rate effect by year-end 2012, progressed according to plan.
  · The Board of Directors proposes a dividend to shareholders of SEK 6.00 per
share (5.00).

Financial information

  · Net asset value amounted to SEK 156,070 m. (SEK 205 per share) on December
31, 2011, compared to SEK 169,386 m. (SEK 223 per share) at year-end 2010,
corresponding to a change, with dividend added back, of -6 percent for 2011
(21). Over the past 5, 10 and 20 years, annual net asset value growth has been
2, 6 and 12 percent respectively.
  · Consolidated net profit for the year, including unrealized change in value,
was SEK -9,288 m. (SEK -12.14 per share), compared to SEK 30,611 m. for 2010
(SEK 40.24 per share).
  · Core Investments contributed negatively by SEK -17,939 m. to net asset value
2011 (29,340), of which Listed SEK -17,889 m. (27,098).
  · Financial Investments contributed positively by SEK 9,687 m. to net asset
value 2011 (1,664).
  · Leverage (net debt/total assets) was 9.8 percent at year-end (6.3).
  · The total return on the Investor share was -8 percent for 2011 (11). The
Stockholm Stock Exchange’s Total Return Index (SIXRX) was -14 percent (27).

For further information:

Oscar Stege Unger, Head of Corporate Communications, Phone 46 8 614 2059, 46 70
624 2059
Magnus Dalhammar, Investor Relations Manager, Phone 46 8 614 2130, 46 73 524
2130